Presence of a hypovascular hepatic nodule showing hypointensity on hepatocyte-phase image is a risk factor for hypervascular hepatocellular carcinoma

Hypovascular hepatic nodule showing hypointensity in the hepatobiliary phase of gadoxetic acid-enhanced MRI in patients with chronic liver disease: Prediction of malignant transformation

(2012) Yukihisa Takayama et al.   EUROPEAN JOURNAL OF RADIOLOGY

Liver stiffness measured by magnetic resonance elastography as a risk factor for hepatocellular carcinoma: a preliminary case–control study

(2012) Utaroh Motosugi et al.   EUROPEAN RADIOLOGY

Hepatobiliary and Pancreatic: Detection of early hepatocellular carcinoma by enhanced magnetic resonance imaging

(2012) Y Eso et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Primovist, Eovist: What to expect?

(2012) Bernard E. Van Beers et al.   JOURNAL OF HEPATOLOGY

Evolution of Hypointense Hepatocellular Nodules Observed Only in the Hepatobiliary Phase of Gadoxetate Disodium–Enhanced MRI

(2011) Takashi Kumada et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

Beyond the Milan Criteria

(2011) Luciano De Carlis et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Outcome of hypovascular hepatic nodules revealing no gadoxetic acid uptake in patients with chronic liver disease

(2011) Utaroh Motosugi et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Incidence of new foci of hepatocellular carcinoma after radiofrequency ablation: role of multidetector CT

(2011) T. V. Bartolotta et al.   Radiologia Medica

Imaging Study of Early Hepatocellular Carcinoma: Usefulness of Gadoxetic Acid–enhanced MR Imaging

(2011) Katsuhiro Sano et al.   RADIOLOGY

CT and MRI Improve Detection of Hepatocellular Carcinoma, Compared With Ultrasound Alone, in Patients With Cirrhosis

(2010) Nam C. Yu et al.   Clinical Gastroenterology and Hepatology

Distinguishing Hypervascular Pseudolesions of the Liver from Hypervascular Hepatocellular Carcinomas with Gadoxetic Acid–enhanced MR Imaging

(2010) Utaroh Motosugi et al.   RADIOLOGY

Liver parenchymal enhancement of hepatocyte-phase images in Gd-EOB-DTPA-enhanced MR imaging: Which biological markers of the liver function affect the enhancement?

(2009) Utaroh Motosugi et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Screening and diagnosis of hepatocellular carcinoma

(2009) Massimo Colombo   LIVER INTERNATIONAL

Obesity Is an Independent Risk Factor for Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients

(2008) Takamasa Ohki et al.   Clinical Gastroenterology and Hepatology